Oct 10 2024

Study: CBD May Improve Mobility in Dogs

A study conducted by researchers from Colorado State University, published in Frontiers in Veterinary Science, evaluated the effects of cannabidiol (CBD) on dogs with mobility impairments.

The double-blind, crossover, placebo-controlled study involved 42 dogs, with 38 completing the trial.

For the study, dogs were randomly assigned to receive either CBD oil or a placebo over 45 days, with a 30-day washout period between treatments. Outcome measures included gait analysis, accelerometry, and clinical assessments.
Continue reading

Oct 10 2024

Study: Cannabis Legalization Linked to Increased Physical Activity

A study published in the Journal of Cannabis Research and accessible online via the U.S. National Library of Medicine investigated the association between cannabis use and physical activity in the United States.

The research, conducted by researchers from Brigham Young University, examined how cannabis legalization and health status influenced this relationship, using data from the Behavior Risk Factor Surveillance System (BRFSS) between 2016 and 2022.

The study found that physical activity among adults increased from 73.16% in 2016 to 75.72% in 2022, while cannabis use rose sharply from 7.48% to 14.71% over the same period. Notably, cannabis use was higher in areas with legalized recreational marijuana (6.5% higher) and legal medical marijuana (0.7% higher) compared to regions where cannabis remained illegal.
Continue reading

Oct 10 2024

Colorado: Over $120 Million in Legal Marijuana Sold in August, Nearly $1 Billion Year-to-Date

Colorado saw over $120 million in legal marijuana sales for the second consecutive month.

According to data from the Colorado Department of Revenue, licensed retail outlets and dispensaries sold $122,481,187 worth of marijuana in August, closely matching the $122,550,314 sold in July. However, this is a decline from the $132 million recorded in August of last year.

Of the total sales in August, approximately $109 million was for recreational use, while medical marijuana sales totaled around $13.5 million.
Continue reading

Oct 10 2024

Northern Mariana Islands Ends Pre-Employment Marijuana Testing for Most Government Jobs

The Governor of the Commonwealth of the Northern Mariana Islands (CNMI), Arnold Palacios, has signed into law legislation eliminating pre-employment marijuana screening for most government positions.

(Photo credit: Emily Koonce)

Public Law 23-2 exempts safety-sensitive roles and those under federal drug testing regulations from this change.

This move comes after the US territory, with a population of around 56,000, legalized the sale and use of cannabis in 2018. The CNMI joins a growing list of states and cities, including Michigan, Nevada, Washington, and major municipalities like Atlanta, Philadelphia, and St. Louis, that have also ended pre-employment marijuana screening for most public employees.
Continue reading

Oct 10 2024

Poll: Over 60% of Pennsylvania Voters Across Five Districts Support Legalizing Marijuana

New polling conducted by Change Research shows strong support for marijuana legalization in Pennsylvania, with more than 60% of voters in five key House districts backing the move to legalize, regulate, and tax cannabis.

The poll, conducted between September 3 and 11, 2024, surveyed 1,695 likely voters in districts across the state and revealed consistent support across all demographics.

In districts like HD16 (Beaver County) and HD151 (Montgomery County), support was particularly strong, with 72% of voters favoring legalization. Other districts, such as HD72 (Cambria County) and HD144 (Bucks County), also showed robust support, ranging from 64% to 65%. Across these districts, voters cited public safety, economic benefits, and criminal justice reform as key reasons for backing legalization.
Continue reading

Oct 10 2024

Nebraska: Legalizing Medical Marijuana Projected to Generate Over $925 Million in Economic Benefits Through 2030

Legalizing and regulating medical cannabis will benefit Nebraska patients and generate over $925 million in new economic activity for local communities according to research from Vicente LLP, a nationally-recognized law firm and leader on cannabis law and policy.

Together, Initiative 437 and Initiative 438 will establish legal protections for patients and their caregivers and create a safe and regulated medical marketplace for Nebraska patients. The initiatives would establish the Nebraska Medical Cannabis Commission to oversee the registration and regulation of individuals involved in the possession, manufacture, distribution, delivery, and dispensing of medical cannabis.

Nebraska Families 4 Medical Cannabis (NF4MC), led by a coalition of families, patients, state senators, and other allies, is working with nationally renowned experts to quantify the economic benefits of legal, regulated medical cannabis in the state.
Continue reading

Oct 09 2024

Florida: Miami Herald Endorses Amendment 3 to Legalize Recreational Marijuana

The Miami Herald has come out in strong support of Amendment 3, a ballot initiative that would legalize the recreational use of marijuana in Florida for everyone 21 and older.

“For more than half a century, America has been fighting a war on drugs that most people agree has failed”, states the Miami Herald. “It focused too often on street arrests of young people of color who spent years in prison for small amounts of marijuana while violent cartels bringing in opioids, cocaine and fentanyl — among the most dangerous drugs — continued doing business.”

They continue: “Now Floridians have a chance to help police direct their resources to where they will matter more — to combat killer drugs — and allow the legal use of marijuana products for adults 21 and older. This can be done with proper monitoring, just as the state oversees the sale of alcohol and tobacco products. Constitutional Amendment 3 proposes to expand Florida’s already legal use of medical marijuana (38 states allow it) to recreational use for adults.”
Continue reading

Oct 09 2024

Analysis of Legal Marijuana States: Dried Marijuana Remains Most Popular Category, Followed by Prerolls, Concentrates, and Edibles

In an analysis of the legal marijuana market across multiple states, dried flower remains the most dominant category, maintaining its popularity as consumers’ go-to product.

According to data from ten state marijuana regulatory agencies (between January and September of this year), including California, Massachusetts, Maine, Illinois, Oregon and Washington, as well as industry insights from the research firm Headset.io, dried marijuana consistently ranks as the top-selling category across the United States. In nearly all states, it maintains a majority of all marijuana and marijuana products sold.

Prerolls follow closely as the second most popular category, with strong sales growth reported in most legal marijuana states. Prerolls make up around 20% to 25% of the overall market, depending on the state. This trend is driven in part by convenience, as more consumers are seeking ready-to-use options that require minimal effort, as well as a boom in popularity for infused prerolls.
Continue reading

Oct 09 2024

Study: Psilocybin Reduces Brain Damage and Aids Recovery in Stroke Animal Model

A recent study published in BMC Neuroscience highlights psilocybin’s potential neuroprotective effects.

Conducted by researchers from Taiwan National Health Research Institutes, China Medical University, and University Hospitals of Cleveland, the study explored how psilocybin—a 5HT2A receptor agonist found in “magic mushrooms”—can reduce brain damage and enhance neurological recovery after stroke.

The study involved adult male and pregnant Sprague-Dawley rats, which were subjected simulated stroke conditions. Psilocybin was administered either before or shortly after the induced stroke.
Continue reading

Oct 09 2024

Study: Edible Cannabis Provides Short- and Long-Term Relief From Chronic Low Back Pain

A new study conducted by researchers from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder has found that edible cannabis may provide both short-term and extended relief for individuals suffering from chronic low back pain.

The study, published in the peer-reviewed journal Frontiers in Pharmacology, examined the effects of edible cannabis products containing varying levels of THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol).

The research tracked 249 participants with a mean age of 46 over two weeks as they self-administered edible cannabis products. The participants used products classified as either THC-dominant, CBD-dominant, or a combination of both, based on their preferences. Pain relief, mood changes, and intoxication effects were evaluated throughout the study.
Continue reading